InterMune (ITMN)
InterMune Revenues: 8.936M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ITMN Revenues Rankings
| Overall | 12th percentile | 3886 of 4432 |
| Sector | 30th percentile | 325 of 470 in Healthcare |
| Industry | 46th percentile | 70 of 132 in Biotechnology |
ITMN Revenues Range, Past 5 Years
| Minimum | 5.229M | Sep 2011 |
| Maximum | 241.66M | Dec 2010 |
| Average | 21.85M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these ITMN related companies
ITMN News
Of coUrse $ITMN only just broke 10.50 but i think it can get close to 11 today and break of that sends it to mid 11's lwhere it was last wk
about 5 days ago by epime7heus
about 5 days ago by epime7heus
Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
May 24, 8:39AM Street Insider
May 24, 8:39AM Street Insider
InterMune (ITMN) to divest ActImmune for $55M in cash, plus a two-year royalty stream
May 21, 4:54PM Street Insider
May 21, 4:54PM Street Insider
Intermune Will Divest Rights to Vidara for $55M in Cash, Plus 2 Year Royalty Stream
May 21, 4:52PM Benzinga
May 21, 4:52PM Benzinga
Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Esbriet (pirfenidone) Positive GBA Assessment
May 21, 10:02AM Street Insider
May 21, 10:02AM Street Insider
Quant modell indicates a 2 - 1 chance for $ITMN not closing above 11.56 today. Now trading at 11.41 or +9.3%
about 29 days ago by TradeBot
about 29 days ago by TradeBot
$ITMN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aRF
about 30 days ago by MarketBrief
about 30 days ago by MarketBrief
@bnichols9883 Don't count $ITMN out; it had a hiccup in sales; not surprising, but I expect a successful P3 trial and US approval in two yrs
about 30 days ago by SlownSteady
about 30 days ago by SlownSteady
$ITMN is -5.9% down since open on unusual high volume and -14.2% down since close.
about 33 days ago by TradeBot
about 33 days ago by TradeBot
Drug Approvals or Rejections have a huge impact on InterMune stock $ITMN, now trading at support level. http://stks.co/3Xsw
about 33 days ago by TradingGraphs
about 33 days ago by TradingGraphs
$ITMN Any thoughts at these levels? Chart looks like it's basing and turning.
about 34 days ago by oddsmaker
about 34 days ago by oddsmaker
Listen to $ITMN Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3XQd
about 34 days ago by earningscast
about 34 days ago by earningscast
InterMune Reports First Quarter 2012 Financial Results And Business Highlights
Apr 26, 4:00PM PR Newswire
Apr 26, 4:00PM PR Newswire
$ITMN http://stks.co/3M1f Watching the support level to see if we hold and bounce or fail ...
about 45 days ago by jamiemc101
about 45 days ago by jamiemc101
UPDATE - UBS Initiates Coverage on Intermune (ITMN) with a Neutral; Overshot to Downside, But Stuck Until More Clarity
Apr 12, 11:13AM Street Insider
Apr 12, 11:13AM Street Insider
Brean Murray Carret & Co. Adjusting Estimates & PT InterMune Inc. (ITMN); Timelines Push Things Back
Apr 10, 8:56AM Street Insider
Apr 10, 8:56AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ITMN | 10.26 | -0.84 | -7.57% | 725.16M |
| ITIC | 51.02 | +0.83 | +1.65% | 105.40M |
| ITI | 1.41 | -0.04 | -2.76% | 48.31M |
| ITC | 68.99 | -0.07 | -0.10% | 3.546B |
| ITA | 62.31 | +0.62 | +1.00% | |
| IT | 40.96 | -0.15 | -0.36% | 3.838B |
| ISTA | 9.095 | -0.01 | -0.05% | 380.11M |
| IST | 20.56 | -0.20 | -0.96% | |
| ISSI | 9.63 | -0.17 | -1.73% | 264.99M |
| ISSC | 3.54 | -0.05 | -1.39% | 58.91M |
